Reason for request
Inclusion on the list of medicines approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this medicinal product is substantial. |
Clinical Added Value
| moderate |
BERINERT provides a moderate improvement in actual benefit (IAB III) in terms of effectiveness in managing episodes of hereditary angioedema in adults and children. |
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
50D7wvBk7GvCtkN5
